The status of compounded tirzepatide is tied directly to the FDAs drug shortage list. The law generally stops pharmacies from making drugs that are essentially a copy of an FDA-approved drug
Of the remaining 15 patients, 5 (33.3%) were female
A Realistic Timeline for Results So, what does the journey actually look like
doi: 10.3389/fcvm.2025.1574489 Received 10 February 2025 Accepted 03 March 2025 Published 25 March 2025 Volume 12 - 2025 Edited by Ryuichi Morishita, Osaka University, Japan Reviewed by Chieko Mineo, University of Texas Southwestern Medical Center, United States Kimie Tanaka, Juntendo University, Japan Updates Copyright 2025 Jha, Nakano, Itto, Barbeiro, Lupieri, Aikawa and Aikawa